Assessment of oral cancer pain, anxiety, and quality of life of oral squamous cell carcinoma patients with invasive treatment procedure
The objective of the current study was to assess the preoperative and postoperative oral cancer pain, anxiety, and quality of life of OSCC patients with invasive treatment procedure.MethodsThe current study was conducted by interviewing 21 (10 males; 11 females) patients who had been diagnosed with stage 3 and stage 4 OSCC and about to go through surgery at the inpatient ward of Surgical Oncology Department, Hasan Sadikin Hospital, Bandung, Indonesia. A preoperative and interview was conducted by using the Hospital Anxiety and Depression Scale (HADS), the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QOL)-C30, the shortened EORTC QOL Questionnaire for Oesophageal Cancer (OES)18, the visual analog scale (VAS), and the University of California San Francisco (UCSF) Oral Cancer Pain Questionnaire. All data were analyzed to evaluate the preoperative and postoperative effect.ResultsThe current study showed a significant decrease of the postoperative oral pain (p
Journal Name: Drug Metabolism and Personalized Therapy Issue: Ahead of print
Conclusions The bEnd3 cell line represents a useful in vitro tool for studying BBB characteristics and drug transport mechanisms at the BBB. PMID: 29683403 [PubMed - as supplied by publisher]
Discussion These results indicated that embelin can effectively suppress CUS-induced depressive-like behaviors through increasing BDNF expression, preventing brain from oxidative stress and neuronal inflammation, and normalizing the HPA activity. PMID: 29681219 [PubMed - as supplied by publisher]
PHYSICAL exercise decreases the chance of developing depression later in life, according to new research today The worldwide study involving more than 250,000 people found that taking exercise protects against depression regardless of a person's age or geographical location.
In KEYNOTE-189, a pembrolizumab/chemo combination yielded OS and PFS benefits in patients with advanced NSCLC.
CRISPR/Cas9 genome editing technology significantly accelerated herpes simplex virus research, Published online: 25 April 2018; doi:10.1038/s41417-018-0016-3CRISPR/Cas9 genome editing technology significantly accelerated herpes simplex virus research
Date: Wednesday, 05 23, 2018; Speaker: Matthew Gamble, Ph.D., Associate Professor, Albert Einstein College of Medicine; Building: Building 41; C507/C509
Albert Thompson was initially denied NHS treatment for prostate cancer until he proved his status.
This study explores the contribution of cyberbullying, unmet medical needs, and other factors to depressive symptoms.Medscape Medical News
Conclusions: These results indicate that ENO2 may be a biological marker for monitoring chemotherapeutic efficacy and relapse in ALL. ENO2 may provide a potential therapeutic strategy for ALL.Cell Physiol Biochem 2018;46:1525 –1535